Implantable Vagus Nerve Stimulation Modulation of Coeruleus-Norepinephrine Network for Mild-Moderate AD Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

September 1, 2026

Study Completion Date

December 31, 2026

Conditions
Alzheimer Disease
Interventions
PROCEDURE

Vagus Nerve Stimulation Modulation of the Coeruleus-Norepinephrine Network

The implant surgery is performed under general anesthesia. The generator is implanted subcutaneously in the left upper chest or left axillary border. The electrode lead wire is attached to the left mid-cervical vagus nerve through a second incision in the left neck area. The lead wire is passed through a subcutaneous tunnel and attached to the pulse generator.

Trial Locations (1)

100053

Xuanwu Hospital, Capital Medical University., Beijing

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER

NCT05575271 - Implantable Vagus Nerve Stimulation Modulation of Coeruleus-Norepinephrine Network for Mild-Moderate AD Patients | Biotech Hunter | Biotech Hunter